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Background/Objective: Diabetic ketoacidosis (DKA) is a life-threatening complication of type 1 
diabetes (T1D) resulting from ketone body production and metabolic acidosis occurring due to 
insulin deficiency. We sought to define the occurrence of DKA amongst pediatric patients 
presenting with new-onset T1D in Indiana and to determine whether patterns of DKA were 
affected by the COVID-19 pandemic.  
 
Methods: This was a retrospective chart review for patients <18 years admitted to Riley 
Children’s Hospital with a clinical diagnosis of new onset T1D who had available chemistry 
values. Patients diagnosed from March 23- June 30, 2020 and over the same period in 2019 
were included. DKA was classified as mild (bicarbonate 10-15 mmol/L) or severe (bicarbonate 
<10 mmol/L). 
 
Results: Ninety-four patients met inclusion criteria. The total number of incident T1D cases in 
2019 and 2020 were similar (48 vs. 46, respectively). Similarly, there was no significant 
difference in rates of DKA (21 in 2019 vs. 25 in 2020; p>0.05). Of the 94 patients, 49% met 
criteria for DKA; 79% of cases were classified as severe and 21% as mild. More males were 
diagnosed with DKA in both 2019 and 2020 (61% of DKA cases). Non-Hispanic whites 
comprised 75% of all new onset T1D patients and no differences in race or ethnicity were 
present amongst those presenting in DKA.  
 
Conclusion: DKA was present in nearly half of all new onset pediatric T1D cases in Indiana in 
2019 and 2020. There was no observed impact of the COVID-19 pandemic on T1D or DKA.   
 
Impact and Implications: DKA is common amongst pediatric patients with new onset T1D in 
Indiana. Prompt recognition of symptoms is needed to prevent this life-threatening complication 
of T1D. 
